Rieko Ohki

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Cancer Stem Cells

Endoplasmic Reticulum

Epidermal Growth Factor Receptor

Top Venues

Genes to cells : devoted to molecular & cellular mechanisms

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms 29 (6) (2024)
Die Hu, Naoya Kobayashi, Rieko Ohki
FUCA1 : An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression. Cancers 16 (15) (2024)
Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms 29 (6) (2024)
Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms 29 (6) (2024)
Die Hu, Naoya Kobayashi, Rieko Ohki
FUCA1 : An Underexplored p53 Target Gene Linking Glycosylation and Cancer Progression. Cancers 16 (15) (2024)
Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms (2024)
Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms 29 (6) (2024)
Rieko Ohki, Koji Itahana, Tomoo Iwakuma
"The 10th International MDM2 Workshop": Opening up new avenues for MDM2 and p53 research, the First International MDM2 Workshop in Asia. Genes to cells : devoted to molecular & cellular mechanisms (2024)
Jayaraman Krishnaraj, Tatsuki Yamamoto, Rieko Ohki
p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment. Cancers 15 (13) (2023)
Yu Chen, Tatsuki Yamamoto, Yura Takahashi, Tomoka Moro, Tomoko Tajima, Yukiko Sakaguchi, Naoaki Sakata, Akihiko Yokoyama, Susumu Hijioka, Akane Sada, Yuko Tabata, Rieko Ohki
Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors. Cell death & disease 14 (9) (2023)
Yuko Nagamura, Makoto Miyazaki, Yoshiko Nagano, Arata Tomiyama, Rieko Ohki, Kazuyoshi Yanagihara, Ryuichi Sakai, Hideki Yamaguchi
SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling. Cancers 13 (17) (2021)
Shiori Suzuki, Shuichi Tsutsumi, Yu Chen, Chikako Ozeki, Atsushi Okabe, Tatsuya Kawase, Hiroyuki Aburatani, Rieko Ohki
Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain. Cancer science 111 (2) (2020)
Yu Chen, Masahiro Takikawa, Shuichi Tsutsumi, Yoko Yamaguchi, Atsushi Okabe, Mayuna Shimada, Tatsuya Kawase, Akane Sada, Issei Ezawa, Yuhei Takano, Kisaburo Nagata, Yutaka Suzuki, Kentaro Semba, Hiroyuki Aburatani, Rieko Ohki
PHLDA1, another PHLDA family protein that inhibits Akt. Cancer science 109 (11) (2018)
Masahiro Takikawa, Rieko Ohki
A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors. Cancer science 108 (6) (2017)